Difference between revisions of "MOC31"

Jump to navigation Jump to search
27 bytes removed ,  17:09, 4 February 2015
no edit summary
Line 1: Line 1:
'''MOC31''' is an [[immunostain]].
'''MOC31''' is an [[immunostain]]. The antibody is directed against the epithelial cell adhesion molecule (Ep-CAM, TACSTD1).<ref name=pmid19391212/>
 
It is useful for differentiating [[hepatocellular carcinoma]] from [[cholangiocarcinoma]] and [[liver metastases]].<ref name=pmid10937059>{{Cite journal  | last1 = Proca | first1 = DM. | last2 = Niemann | first2 = TH. | last3 = Porcell | first3 = AI. | last4 = DeYoung | first4 = BR. | title = MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. | journal = Appl Immunohistochem Mol Morphol | volume = 8 | issue = 2 | pages = 120-5 | month = Jun | year = 2000 | doi =  | PMID = 10937059 }}</ref>


==Negative==
==Negative==
*[[Hepatocellular carcinoma]].<ref name=pmid10937059/>
*[[Hepatocellular carcinoma]].<ref name=pmid10937059>{{Cite journal  | last1 = Proca | first1 = DM. | last2 = Niemann | first2 = TH. | last3 = Porcell | first3 = AI. | last4 = DeYoung | first4 = BR. | title = MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. | journal = Appl Immunohistochem Mol Morphol | volume = 8 | issue = 2 | pages = 120-5 | month = Jun | year = 2000 | doi =  | PMID = 10937059 }}</ref>
*[[Malignant mesothelioma|Malignant epithelioid mesothelioma]] - usually negative.<ref name=pmid9490276/>
*[[Malignant mesothelioma|Malignant epithelioid mesothelioma]] - usually negative.<ref name=pmid9490276/>


48,830

edits

Navigation menu